These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 176936)

  • 1. In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).
    Kuck NA
    Antimicrob Agents Chemother; 1976 Mar; 9(3):493-7. PubMed ID: 176936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens.
    Maderazo EG; Quintiliani R; Tilton RC; Bartlett R; Joyce NC; Andriole VT
    Antimicrob Agents Chemother; 1975 Jul; 8(1):54-7. PubMed ID: 1099982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.
    Montgomerie JZ; Pickett MJ; Yoshimori RN; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1976 Jul; 10(1):102-5. PubMed ID: 791084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Acinetobacter calcoaceticus (Herellea vagincola) to tetracycline and minocycline.
    Thomas ET; Coleman C; Talantis K; Armstrong M
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):140-4. PubMed ID: 812659
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibilities of Pseudomonas species to tetracycline, minocycline, gentamicin, and tobramycin.
    Tilton RC; Steingrimsson O; Ryan RW
    Am J Clin Pathol; 1978 Apr; 69(4):410-3. PubMed ID: 645640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.
    Castanheira M; Mendes RE; Jones RN
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S367-73. PubMed ID: 25371512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus.
    Obana Y; Nishino T; Tanino T
    J Antimicrob Chemother; 1985 Apr; 15(4):441-8. PubMed ID: 4008377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of minocycline and other antibiotics on Fusobacterium necrophorum infections in mice.
    Kuck NA
    Antimicrob Agents Chemother; 1975 Apr; 7(4):421-5. PubMed ID: 1147577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibiotic susceptibility of bacteria isolated from prostatic fluid.
    Drach GW
    Urology; 1979 Sep; 14(3):237-40. PubMed ID: 258548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Flamm RK; Shortridge D; Castanheira M; Sader HS; Pfaller MA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.
    Crues JV; Murray BE; Moellering RC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):690-2. PubMed ID: 526013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution and changes of antibiotic susceptibility of genus Haemophilus (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1976 Feb; 29(2):159-66. PubMed ID: 1046091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
    Dabernat H; Delmas C; Bauriaud R; Lareng MB
    Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2.
    Tan TY; Ng LS; Poh K
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):357-61. PubMed ID: 17467946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].
    Dickgiesser N; in der Stroth S; Wundt W
    Infection; 1986; 14(2):82-5. PubMed ID: 2940188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.